Home LiteratureArticle Details

PMID: 16800982 Published · ppublish English Journal Article Research Support, N.I.H., Intramural

A randomized phase II study of docetaxel alone or in combination with PANVAC-V (vaccinia) and PANVAC-F (fowlpox) in patients with metastatic breast cancer (NCI 05-C-0229).

Clinical breast cancer ·Vol. 7 ·No. 2 ·2006-06-00 ·Pages 176-9

Arlen PM, Pazdur M, Skarupa L, Rauckhorst M, Gulley JL

Abstract

暂无摘要

MeSH Terms

Antineoplastic Agents, Phytogenic/administration & dosage Antineoplastic Combined Chemotherapy Protocols/administration & dosage Breast Neoplasms/drug therapy,pathology Cancer Vaccines/administration & dosage Clinical Trials, Phase II as Topic Docetaxel Female Humans Neoplasm Metastasis Poxviridae/immunology Randomized Controlled Trials as Topic Research Design Taxoids/administration & dosage

Chemicals

Antineoplastic Agents, Phytogenic Cancer Vaccines Taxoids Docetaxel

Authors & Affiliations

5 authors, click to expand affiliations / ORCID

Arlen Philip M

Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute/National Institutes of Health, Bethesda, MD 20892-1750, USA. [email protected]

Pazdur Mary

Skarupa Lisa

Rauckhorst Myrna

Gulley James L

Article Info

Journal

Clinical breast cancer

Abbr.

Clin Breast Cancer

ISSN

1526-8209

DOI

10.3816/CBC.2006.n.032

[email protected]

Published

2006-06-00

Pages

176-9

Language

English

Region

United States

NLM ID

100898731

Subset

Grants

Intramural NIH HHS · United States

External Links

PubMed source DOI: 10.3816/CBC.2006.n.032 View journal details

Analysis Services

A randomized phase II study of docetaxel alone or in combination with PANVAC-V (vaccinia) and PANVAC-F (fowlpox) in patients with metastatic breast cancer (NCI 05-C-0229).

Contact

WeChat Official Account